- A U.S. District Court denies Antares Pharma's (ATRS +1.1%) motion for a preliminary injunction against Medac Pharma to prevent it from selling its methotrexate auto-pen product if and when it earns regulatory approval. Antares sued Medac in February for patent infringement and filed a motion for preliminary injunction a month later. If the parties fail to settle, the litigation will proceed to a jury trial although no trial date has been set yet.
Adverse court ruling for Antares
Recommended For You
About HALO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
HALO | - | - |
Halozyme Therapeutics, Inc. |